van Echten J, Sleijfer D T, Wiersema J, Schraffordt Koops H, Oosterhuis J W, de Jong B
Department of Medical Genetics, University of Groningen, The Netherlands.
Cancer Genet Cytogenet. 1997 Jul 1;96(1):1-6. doi: 10.1016/s0165-4608(96)00284-1.
Residual mature teratoma (RMT) is often left behind when metastases of primary nonseminomatous germ cell tumors (NSs) are treated with chemotherapy. RMT is composed of fully differentiated somatic tissue. A growing teratoma (GTE) lesion may occur after (incomplete) resection of RMT. To shed light on tumor progression or the mechanism(s) of therapy related differentiation we investigated the chromosomal pattern of the primary NSs and RMTs in twelve patients, of the primary NS, RMT, and GTE lesion in one patient, and of the RMT and GTE lesion in two patients. Although several chromosomal differences are observed between the RMT and NSs and between the GTE and RMTs in the same patient, we obtained no evidence that specific chromosomal alteration(s) play a role in metastasis or differentiation.
原发性非精原性生殖细胞肿瘤(NSs)转移灶接受化疗时,常残留成熟畸胎瘤(RMT)。RMT由完全分化的体细胞组织构成。RMT(不完全)切除后可能出现生长中畸胎瘤(GTE)病变。为阐明肿瘤进展或治疗相关分化机制,我们研究了12例患者原发性NSs和RMTs的染色体模式、1例患者原发性NS、RMT及GTE病变的染色体模式以及2例患者RMT和GTE病变的染色体模式。尽管在同一患者的RMT与NSs之间以及GTE与RMT之间观察到了一些染色体差异,但我们没有获得证据表明特定的染色体改变在转移或分化中起作用。